TY - JOUR
T1 - Human papillomavirus vaccine motivators and barriers among community college students
T2 - Considerations for development of a successful vaccination program
AU - Hirth, Jacqueline
AU - Batuuka, Denise N.
AU - Gross, Tyra T.
AU - Cofie, Leslie
AU - Berenson, Abbey B.
N1 - Funding Information:
Dr. Hirth was a Scholar supported by a research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women’s Health Program –BIRCWH; Principal Investigator: Berenson) from the Office of Research on Women’s Health ( ORWH ), the Office of the Director (OD), the Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD ) at the National Institutes of Health during data collection and analyses for this study. Federal support for manuscript preparation was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD ) to Dr. Tyra Gross and Dr. Leslie Cofie, as National Research Service Award postdoctoral fellows under an institutional training grant (T32HD055163; PI: AB Berenson). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health .
Publisher Copyright:
© 2018
PY - 2018/2/14
Y1 - 2018/2/14
N2 - Background: Previous interventions in colleges to improve human papillomavirus (HPV) vaccination have not been highly successful. Although barriers have been assessed in traditional colleges, less is known about vaccination barriers in community colleges. Methods: We approached students aged 18–26 years old enrolled at a community college for an in-person semi-structured qualitative interview on HPV vaccination and health, with questions guided by the Theory of Planned Behavior. Data collection took place between April 2015 and December 2015. Thematic analysis techniques were used to analyze the data. Results: During interviews with 19 students, 4 themes emerged, including: general vaccine attitudes, barriers to HPV vaccination, motivators to HPV vaccination, and social influences. Participants felt that vaccines were beneficial, but were concerned about side effects. They felt that getting the HPV vaccine would be inconvenient, and they did not know enough about it to decide. Most would not trust their friends’ opinions, but would want to know about side effects that their vaccinated friends experienced. Conclusions: Successful interventions at community colleges should include several components to increase convenience as well as utilize interactive methods to promote HPV vaccine awareness.
AB - Background: Previous interventions in colleges to improve human papillomavirus (HPV) vaccination have not been highly successful. Although barriers have been assessed in traditional colleges, less is known about vaccination barriers in community colleges. Methods: We approached students aged 18–26 years old enrolled at a community college for an in-person semi-structured qualitative interview on HPV vaccination and health, with questions guided by the Theory of Planned Behavior. Data collection took place between April 2015 and December 2015. Thematic analysis techniques were used to analyze the data. Results: During interviews with 19 students, 4 themes emerged, including: general vaccine attitudes, barriers to HPV vaccination, motivators to HPV vaccination, and social influences. Participants felt that vaccines were beneficial, but were concerned about side effects. They felt that getting the HPV vaccine would be inconvenient, and they did not know enough about it to decide. Most would not trust their friends’ opinions, but would want to know about side effects that their vaccinated friends experienced. Conclusions: Successful interventions at community colleges should include several components to increase convenience as well as utilize interactive methods to promote HPV vaccine awareness.
KW - Access to HPV vaccination
KW - Community college
KW - HPV vaccination barrier
KW - HPV vaccine education
KW - HPV vaccine promotion
UR - http://www.scopus.com/inward/record.url?scp=85040654885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040654885&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2018.01.037
DO - 10.1016/j.vaccine.2018.01.037
M3 - Article
C2 - 29366708
AN - SCOPUS:85040654885
VL - 36
SP - 1032
EP - 1037
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 8
ER -